IL1R2 and COVID-19: The increased expression of IL-1 inhibitory receptor 2 (IL1R2) in MDSC monocytes is interesting considering the role of dysregulated monocyte responses and elevated levels of serum inflammatory cytokine, including IL-1β reported in severe COVID-19 patients [42, 44, 45].